So ... I am trying to join the dots here (IMHO)
In the many interviews LC has conducted, particularly around HER-Vaxx, I recall LC saying that (early on) that IMU could not to conduct Phase-3 trials because you need about $100M to do it. Also, in the last interview with ASX investor, LC said that they have not released final results of Phase-2 because patients are surviving and not dying (we don't want people to die).
So my guess is that the CR of $80M (as per AFR article) is in the ballpark on what LC mentioned it costs to fund Phase-3 trials for HER-Vaxx.
Again, this is my opinion - as always DYOR
Good luck to all long term holders !!
Ann: Trading Halt, page-377
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |